Nausea is the most common side effect of GLP-1 receptor agonist medications
Semaglutide (Ozempic and Wegovy) Semaglutide is the most widely used GLP-1 receptor agonist for weight loss
4.4 Potential effects of tirzepatide on upper airway function In addition to metabolic and inflammatory modulation, emerging evidence suggests that incretin-based therapies may influence upper airway neuromuscular control
In response to growing criticism of the cost of their drugs, Novo Nordisk, the company that manufactures Ozempic and Wegovy, reported last year that rebates and other fees (across all payers) accounted for about 40% of the cost of the two drugs and that they expected rebates to grow
A 2022 study published in The Journal of Clinical Endocrinology & Metabolism found that patients with type 2 diabetes using GLP-1 medications reported lower levels of depression and anxiety symptoms (Lee et al., 2022)
Peak is cash-pay only and does not require labs by default, ordering them selectively based on your intake
